InnoBM

InnoBM is a South Korean biotechnology company specializing in the development of advanced bone regenerative therapeutics. The company's core technology is centered on the high-efficiency production of recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) using a proprietary E. coli-based expression system. This platform allows for the creation of high-purity biologics that stimulate osteoblast differentiation and accelerate bone healing. InnoBM's lead product, Inno-BMP2, is primarily targeted at dental bone grafting and orthopedic applications such as spinal fusion and fracture repair. By providing a potent osteoinductive signal, the company aims to improve clinical outcomes in patients with significant bone defects. InnoBM is positioned as a key provider of biological solutions in the global regenerative medicine market.